Global

Pediatrics Experts

Kanwaldeep Mallhi

Assistant Professor
Pediatric Hematology/Oncology
Fred Hutchinson Cancer Rearch Center
United States of America

Biography

Dr. Mallhi specializes in hematopoeitic stem cell transplantation for the treatment of patients with childhood cancers and nonmalignant disorders. Specifically focused on patients with inborn errors of metabolism, marrow failure syndromes, primary immunodeficiencies, hemoglobinopathies and histiocytic disorders. Other clinical interests include the use of alternative donor sources such as umbilical cord blood and haploidentical donors, as well as prevention of acute transplant related complications and studying the long-term effects of transplantation. Education & Training MD:  Rosalind Franklin University of Medicine and Science- Chicago Medical School Residency:  Pediatrics, SUNY- University of Buffalo Fellowship:  Pediatric Hematology/Oncology: University of British Columbia; Pediatric BMT: University of Minnesota

Research Interest

Dr. Mallhi is working to improve outcomes for patients with non-malignant disorders who undergo hematopoietic stem cell transplantation involving reduced intensity conditioning regimens and alternative donor sources.

Publications

  • Ca2+-mediated ascorbate release from coronary artery endothelial cells. Davis, K. A., Samson, S. E., Best, K., Mallhi, K. K., Szewczyk, M., Wilson, J. X., Kwan, C. Y., Grover, A. K.; Br J Pharmacol. 2006 Jan.

  • Aortic smooth muscle and endothelial plasma membrane Ca2+ pump isoforms are inhibited differently by the extracellular inhibitor caloxin 1b1. Pande, J., Mallhi, K. K., Sawh, A., Szewczyk, M. M., Simpson, F., Grover, A. K.; Am J Physiol Cell Physiol. 2006 May.

  • Hematopoietic cell transplantation and cellular therapeutics in the treatment of childhood malignancies. Mallhi K Lum LG Schultz KR Yankelevich M; Pediatr Clin North Am. 2015 Feb .

  • Functional hyposplenism after hematopoietic stem cell transplantation. Rozmus J Mallhi K Ke J Schultz KR; Bone Marrow Transplant. 2015 Jul 13 .

  • Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review... Mallhi, K.,Orchard, P. J.,Miller, W. P.,Cao, Q.,Tolar, J.,Lund, T. C.; Bone Marrow Transplant.. 2017 Jan 17.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America